image credit: Unsplash

Boosting Capabilities in Gene and Cell Therapy Bioprocessing

A new company has been founded to supply software for managing cell & gene therapy manufacturing.

Autolomous, founded in February 2019, has already secured four different clients whom they hope to assist with digitizing and streamlining their workflows.

“There’s a gap around handling manufacturing data in cell and gene therapy manufacturing,” explains Kwok Pang, the company’s co-founder and COO. “So, what we’re doing is providing that missing piece of the puzzle to help drive efficiency across the supply chain.”

Read More on Genetic Engineering and Biotechnology News